Breaks Categories: News

WednesdayFeb 24, 2021 10:44 am

NetworkNewsBreaks – Ideanomics (NASDAQ: IDEX) Announces Presence at Three Upcoming Conferences

Ideanomics (NASDAQ: IDEX), a global company focused on the convergence of financial services and industries experiencing technological disruption, along with two portfolio companies — WAVE (“WAVE”) and Selectrac — will be presenting at three virtual conferences, all scheduled in March. WAVE’s Michael Masquelier will present at the Global Transmission Conference, schedule for March 4, 2021. Masquelier’s 40-minute presentation will begin at 1:15 p.m. ET. Solectrac founder and CEO Steve Heckeroth will present at FORCE for Knowledge: Food Tech 101 on March 10, 2021. His one-hour presentation will begin at 11 a.m. ET. Ideanomics CEO Alf Poor will participate in an EV panel at…

Continue Reading

WednesdayFeb 24, 2021 10:18 am

NetworkNewsBreaks — MustGrow Biologics Corp. (CSE: MGRO) (OTCQX: MGROF) (FRA: 0C0) Announces Receipt of Regulatory Approval Powdery Mildew Bio-Fungicide in Canada

MustGrow Biologics (CSE: MGRO) (OTCQX: MGROF) (FRA: 0C0), an agriculture biotech company focused on providing natural science-based biological solutions for high-value crops, has received regulatory approval from Canada’s Pest Management Regulatory Agency (“PMRA”) for use of a powdery mildew bio-fungicide product; the approval covers use of the powdery mildew bio-fungicide suppression treatment on cannabis and hemp products. MustGrow announced more than a year ago that it had completed a definitive licensing agreement to obtain the exclusive treatment from a leading multinational biological and microbial company. The bio-fungicide product, which is not mustard derived, like MustGrow’s other products, is designed to…

Continue Reading

WednesdayFeb 24, 2021 10:11 am

NetworkNewsBreaks – XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Announces First Order for Rapid COVID-19 Test

XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT), a bioscience accelerator focused on next-generation drug delivery, diagnostic and new active pharmaceutical ingredient investment opportunities, has placed an initial order for rapid point-of-care SARS-CoV-2 (COVID-19) RT-PCR test system. The test systems, known as COVID-ID Labs, were ordered from XPhyto’s exclusive diagnostic development partner, 3a-diagnostics GmbH ("3a"). The first order consists of 9,600 individual tests; the tests are packaged in 200 kits of 48 tests each. The tests, which should arrive by mid-March 2021, will be used as samples for review and evaluation and will be primarily given to prospective distribution partners and licensees…

Continue Reading

WednesdayFeb 24, 2021 10:03 am

NetworkNewsBreaks – Friendable Inc.’s (FDBL) Fan Pass Live Sees 100% Growth in Live Stream Events, Artist Performances

Friendable (OTC: FDBL), a mobile technology and marketing company focused on connecting and engaging users through its proprietary mobile and desktop applications, has released an update on its Fan Pass platform. The platform is seeing validating signs in several key categories of growth metrics, including 100% growth in live-stream events and artist performances. FDBL noted that as the month ends, it anticipates that activity will continue to increase, resulting in numbers higher than seen in January 2021. “Metrics mean everything, no matter whether they’ve increased or decreased, and they continue to guide our team on the journey toward success on…

Continue Reading

WednesdayFeb 24, 2021 9:48 am

NetworkNewsBreaks – AzurRx BioPharma Inc. (NASDAQ: AZRX) Appoints New Chairman of the Board

AzurRx BioPharma (NASDAQ: AZRX), a clinical stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (“GI”) diseases, today announced the appointment of James Sapirstein, president and CEO, as chairman of the company’s board of directors, effective immediately. Sapirstein succeeds Edward J. Borkowski, who joined the AzurRx board in May 2015 and has served as chairman since April 2016. Borkowski will remain as lead independent director of the board of directors. “Having served on AzurRx’s board since 2015, I am committed to ensuring a prosperous future for the company,” said Borkowski. “Under James’ leadership, AzurRx has strategically expanded…

Continue Reading

WednesdayFeb 24, 2021 9:32 am

NetworkNewsBreaks – Predictive Oncology (NASDAQ: POAI) Closes $17.6M Private Placement; Reaches Key Milestones in Developing AI-Driven Model of Ovarian Cancer

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery closed on its previously announced private placement of common stock and warrants. Priced at-the-market under Nasdaq rules, the 9,043,766 shares of common stocks and warrants were issued and sold by the company in order to purchase no more than 4,521,883 shares of common stock in the private placement. The common stock and associated warrants were issued for $1.95 each, with the warrants having an exercise price of $2 per share. The shares are exercisable immediately; however, they do have a five and…

Continue Reading

TuesdayFeb 23, 2021 12:29 pm

NetworkNewsBreaks – RIV Capital Inc. (formerly Canopy Rivers Inc.) (TSX: RIV) (OTC: CNPOF) Closes Plan of Arrangement to Pave Way for U.S. Market Entry

RIV Capital (formerly Canopy Rivers) (TSX: RIV) (OTC: CNPOF) has completed the previously announced plan of arrangement involving Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC). Under the arrangement, RIV Capital, through its wholly-owned subsidiary, RIV Capital Corporation (formerly Canopy Rivers Corporation), transferred its interests in TerrAscend Corp., TerrAscend Canada Inc., Les Serres Vert Cannabis Inc. ("Vert Mirabel") (other than the shares transferred to Serres Bertrand), and The Tweed Tree Lot Inc. (collectively, the "transferred assets") to Canopy Growth. The assets were transferred in exchange for approximately $115 million in cash, 3,647,902 common shares of Canopy Growth (having a value of…

Continue Reading

TuesdayFeb 23, 2021 11:45 am

NetworkNewsBreaks – Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Submits Sales License Application to Health Canada

Pure Extracts Technologies (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ), a plant-based extraction company specializing in cannabis, hemp, functional mushrooms and the rapidly emerging psychedelic sector, announced that, through its wholly owned subsidiary Pure Extracts Manufacturing Corp., it has submitted an application to Health Canada to amend its current license to permit the sale of cannabis extract products. Pure Extracts plans to sell such extracts to provincially authorized distributors and retailers nationwide. This announcement comes on the heels of the company entering a distribution agreement with a large Canadian Licensed Producer to distribute Pure Extracts’ vape and edible products. The company…

Continue Reading

TuesdayFeb 23, 2021 11:25 am

NetworkNewsBreaks – The Alkaline Water Company Inc. (CSE: WTER) (NASDAQ: WTER) Enters Strategic Agreement to Distribute Brands Across Arizona

The Alkaline Water Company (CSE: WTER) (NASDAQ: WTER), a producer of premium bottled alkaline water and flavor-infused water products, today announced that it is partnering with Hensley Beverage Company, a local direct-store-delivery (“DSD”) provider, to distribute its beverage brands across Arizona. “We are pleased to announce we have entered into an agreement with Hensley Beverage Company, an Anheuser-Busch InBev distributor,” said Ricky Wright, president and CEO of The Alkaline Water Company. “Hensley is one of the largest and most respected family-owned beverage distributors in the nation. They service all of Arizona, and its customer base includes over 9,000 retail locations.…

Continue Reading

TuesdayFeb 23, 2021 11:07 am

NetworkNewsBreaks – iClick Interactive Asia Group Limited (NASDAQ: ICLK) Announces Strategic Partnership in China

iClick Interactive Asia Group (NASDAQ: ICLK), an independent online marketing and enterprise data solutions provider, today announced that it has entered into a partnership with HubSpot Inc. (NYSE: HUBS), a leading growth platform, to empower HubSpot's global customers in the areas of WeChat commerce, CRM and marketing SaaS solutions in China. According to the update, the partnership is enabled through iClick's acquisition of the business of Parllay, a long-term technology partner of HubSpot. "HubSpot and iClick's integrated client service capabilities are a game changer for giving companies a truly leading SaaS offering to support their sales and marketing needs in…

Continue Reading